IP Library Granted Patent US 8,529,920
Granted Patent B2
US 8,529,920 · App. 13/062,021 · Granted Sep 10, 2013

Low pH retinoid topical compositions

Inventors: Limin Liu (Palatine, IL); Ralph Spindler (Palatine, IL); Gholam-Reza Vakili-Tahami (Naperville, IL)
Assignee: Amcol International Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,529,920
App. No.
13/062,021
Granted
Sep 10, 2013
Kind
B2
Abstract

A low pH composition containing a retinol and a method for treating skin is disclosed. The composition contains (a) a retinoid and (b) an active acid, like an alpha-hydroxy acid or a beta-hydroxy acid, and has a pH of less than 5.

Claims (21)

1. A water-in-oil emulsion containing composition comprising: a. a water-in-oil emulsion, and b. a retinoid loaded onto polymeric microparticles, wherein the microparticles are dispersed in the oil phase, and having a pH below 5.0, wherein the composition retains greater than 70% by weight of the retinoid present in the composition after 24 weeks at 40° C., or greater than 70% by weight of the retinoid present in the composition after 12 weeks at 45° C., and wherein the composition includes about 50% to about 80% by weight water.

2. The composition of claim 1 wherein said retinoid is selected from the group consisting of all-trans retinol, retinol, retinaldehyde, retinal, retinyl acetate, retinyl palmitate, retinoic acid, retinyl propionate, retinyl linoleate, dehydroretinol, eretinate, eretrin, motretinide, a synthetic retinoid, and mixtures thereof.

3. The composition of claim 1 comprising about 0.01% to about 2% retinoid by weight of the composition.

4. The composition of claim 1 wherein the retinoid is loaded onto the polymeric microparticles in an amount to provide loaded microparticles containing about 2% to about 80% of the retinoid, by weight.

5. The composition of claim 4 wherein the polymeric microparticles are selected from the group consisting of a copolymer of allyl methacrylate and ethylene glycol dimethacrylate, a copolymer of ethylene glycol dimethacrylate and lauryl methacrylate, a copolymer of methyl methacrylate and ethylene glycol dimethacrylate, a copolymer of 2-ethylhexyl acrylate, styrene, and divinylbenzene, and mixtures thereof.

6. The composition of claim 1 wherein the polymeric microparticles comprise a copolymer of allyl methacrylate and ethylene glycol dimethacrylate, a copolymer of ethylene glycol dimethacrylate and lauryl methacrylate, or a mixture thereof.

7. The composition of claim 5 wherein the polymeric microparticles comprise a copolymer of ethylene glycol dimethacrylate and methyl methacrylate.

8. The composition of claim 1 further comprising a dermatologically active acid selected from the group consisting of an alpha-hydroxy carboxylic acid, a beta-hydroxy carboxylic acid, ascorbic acid, and mixtures thereof.

9. The composition of claim 8 wherein the alpha-hydroxy acid comprises citric acid, glycolic acid, lactic acid, a salt thereof, or mixtures thereof.

10. The composition of claim 8 wherein the beta-hydroxy acid comprises salicylic acid.

11. The composition of claim 8 comprising about 0.03% to about 10% of the active acid by weight of the composition.

12. The composition of claim 9 comprising about 0.1% to about 10% of the active acid, by weight of the composition, and about 0.01% to about 2% of the retinoid, by weight of the composition.

13. The composition of claim 10 comprising about 0.03% to about 10% salicylic acid, by weight of the composition, and about 0.01% to about 2% of the retinoid, by weight of the composition.

14. The composition of claim 1 further comprising a chelating agent.

15. The composition of claim 14 further comprising an oil-soluble antioxidant.

16. The composition of claim 14 wherein the chelating agent is selected from the group consisting of ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid (DTPA), N-(hydroxy ethyl)ethylenediaminetriacetate acid (HEDTA), nitrilotriacetic acid, a salt thereof, a derivative thereof, and mixtures thereof.

17. The composition of claim 15 wherein the oil-soluble antioxidant comprises butylated hydroxytoluene, butylated hydroxyanisole, ascorbyl palmitate, alpha-tocopherol, or mixtures thereof.

18. The composition of claim 14 wherein the chelating agent is present in an amount of about 0.01% to about 1% by weight of the composition.

19. The composition of claim 15 wherein the antioxidant is present in an amount of about 0.01% to about 1%, by weight of the composition.

20. A method of treating mammalian skin comprising contacting the skin with a composition of claim 1 in a sufficient amount to reduce fine lines and wrinkles in the skin.

21. The method of claim 20 wherein the mammalian skin is human skin.

Assignments (3)
SECURITY INTEREST Recorded May 15, 2014
From: AMCOL INTERNATIONAL CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 032918/0776 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR TO AMCOL INTERNATIONAL CORPORATION PREVIOUSLY RECORDED ON REEL 026278 FRAME 0978. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 25, 2011
From: SPINDLER, RALPH; VAKILI-TAHAMI, GHOLAM-REZA; LIU, LIMIN
To: AMCOL INTERNATIONAL CORPORATION
Reel/Frame 026334/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2011
From: SPINDLER, RALPH; VAKILI-TAHAMI, GHOLAM-REZA; LIU, LIMIN
To: BASF SE
Reel/Frame 026278/0978 →
Continuity (2)
Provisional Application 61096506 · Sep 12, 2008
Related Publication 20110189249A1 · Aug 4, 2011